Cysteine protease inhibitors containing heterocyclic leaving groups

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5486623
SERIAL NO

08164031

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A class of cysteine protease inhibitors which inactivate a cysteine protease by covalently bonding to the protease and releasing a heterocyclic leaving group is presented. The cysteine protease inhibitors of the present invention comprise a first portion which targets a desired cysteine protease and positions the inhibitor near the thiolate anion portion of the active site of the protease, and a second portion which covalently bonds to the cysteine protease and irreversibly deactivates that protease by providing a carbonyl or carbonyl-equivalent which is attacked by the thiolate anion of the active site of the cysteine protease to sequentially cleave a heterocyclic leaving group. The heterocyclic leaving group of the protease inhibitor is of the formula: --O-- Het, where Het is a heterocycle having 4-7 atoms in the ring, with at least one of the heterocycle atoms being N, O or S.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROTOTEK INC6747 SIERRA CT DUBLIN CA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Smith, Robert E Livermore, CA 99 3462
Zimmerman, Mary P Pleasonton, CA 9 123

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation